The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a proximal molecular phenotype, then a disease-relevant phenotype, in that order.
Curated pathway from expert analysis
flowchart TD
A["TDP-43 Nuclear Clearance Cascade<br/>ALS Motor Neuron Degeneration Mechanism"]
B["Perturbation-First Validation Required<br/>Confirm Causal Sequence"]
C["TDP-43 Restoration Strategies<br/>AAV9, antisense oligonucleotides, small molecules"]
D["Motor Neuron Function Recovery<br/>Electrophysiology and Survival Assays"]
E["Cryptic Exon Splicing Reversal<br/>STMN2, UNC13A Normalization"]
F["ALS Therapeutic Candidate<br/>TDP-43 Clearance Prevention Evidence"]
A --> B
B --> C
C --> D
D --> E
E --> F
style A fill:#4a148c,stroke:#ce93d8,color:#ce93d8
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9aNo linked papers recorded for this hypothesis yet.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for this gene.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.